| Primary |
| Hypertension |
39.0% |
| Product Used For Unknown Indication |
31.9% |
| Type 2 Diabetes Mellitus |
3.5% |
| Cardiac Failure |
3.1% |
| Drug Use For Unknown Indication |
2.4% |
| Pain |
2.4% |
| Depression |
1.9% |
| Atrial Fibrillation |
1.8% |
| Coronary Artery Disease |
1.7% |
| Diabetes Mellitus |
1.5% |
| Myocardial Ischaemia |
1.4% |
| Angina Pectoris |
1.3% |
| Glomerulonephritis Membranous |
1.2% |
| Prophylaxis |
1.1% |
| Blood Pressure |
1.1% |
| Myocardial Infarction |
1.0% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Hypothyroidism |
0.9% |
| Cardiac Disorder |
0.9% |
| Hypercholesterolaemia |
0.9% |
|
| Renal Failure Acute |
13.8% |
| Syncope |
8.2% |
| Vomiting |
8.1% |
| Angioedema |
5.8% |
| Swollen Tongue |
5.8% |
| Hyponatraemia |
5.6% |
| Drug Interaction |
5.4% |
| Hyperkalaemia |
5.2% |
| Cough |
5.1% |
| Dyspnoea |
4.6% |
| Lip Swelling |
4.2% |
| Nausea |
3.8% |
| Hypotension |
3.6% |
| Bradycardia |
3.2% |
| Wheezing |
3.2% |
| Gout |
3.0% |
| Vision Blurred |
3.0% |
| Malaise |
2.8% |
| Renal Failure |
2.8% |
| Swelling Face |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
26.4% |
| Hypertension |
22.8% |
| Drug Use For Unknown Indication |
14.2% |
| Cerebrovascular Accident Prophylaxis |
3.4% |
| Cardiac Failure |
3.2% |
| Diabetes Mellitus |
3.2% |
| Atrial Fibrillation |
3.2% |
| Cardiovascular Disorder |
3.2% |
| Type 2 Diabetes Mellitus |
2.9% |
| Hypercholesterolaemia |
2.8% |
| Pain |
1.8% |
| Spinal Osteoarthritis |
1.8% |
| Coronary Artery Disease |
1.6% |
| Depression |
1.6% |
| Prophylaxis |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Blood Pressure |
1.4% |
| Myocardial Infarction |
1.2% |
| Angina Pectoris |
1.1% |
| Myocardial Ischaemia |
1.1% |
|
| Renal Failure Acute |
20.5% |
| Syncope |
9.5% |
| Renal Failure |
8.4% |
| Vomiting |
8.2% |
| Somnolence |
6.0% |
| Hallucination |
5.4% |
| Hyponatraemia |
4.7% |
| Hypotension |
4.7% |
| Hyperkalaemia |
4.2% |
| Angioedema |
4.1% |
| Suicide Attempt |
3.0% |
| Toxic Epidermal Necrolysis |
2.7% |
| Completed Suicide |
2.6% |
| Fall |
2.6% |
| Overdose |
2.5% |
| Transient Ischaemic Attack |
2.3% |
| Tubulointerstitial Nephritis |
2.3% |
| Rhabdomyolysis |
2.1% |
| Swollen Tongue |
2.1% |
| Renal Impairment |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.0% |
| Drug Use For Unknown Indication |
16.9% |
| Hypertension |
16.0% |
| Rheumatoid Arthritis |
4.6% |
| Diabetes Mellitus |
3.7% |
| Atrial Fibrillation |
3.1% |
| Prophylaxis |
2.8% |
| Type 2 Diabetes Mellitus |
2.6% |
| Pain |
2.6% |
| Depression |
2.0% |
| Coronary Artery Disease |
2.0% |
| Hypercholesterolaemia |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Osteoporosis |
1.5% |
| Cardiac Failure |
1.3% |
| Breast Cancer |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Hyperlipidaemia |
1.1% |
| Myocardial Ischaemia |
1.1% |
| Multiple Myeloma |
1.0% |
|
| Vomiting |
13.0% |
| Renal Failure Acute |
7.7% |
| Weight Decreased |
6.5% |
| Rhabdomyolysis |
6.2% |
| Myocardial Infarction |
6.2% |
| Syncope |
5.8% |
| Renal Failure |
5.0% |
| Death |
5.0% |
| Thrombocytopenia |
4.5% |
| Urinary Tract Infection |
4.5% |
| Pyrexia |
4.0% |
| Drug Interaction |
3.8% |
| Pneumonia |
3.8% |
| Nausea |
3.7% |
| Tremor |
3.6% |
| Dyspnoea |
3.5% |
| Weight Increased |
3.4% |
| Pulmonary Embolism |
3.3% |
| Sepsis |
3.3% |
| Pruritus |
3.2% |
|
| Interacting |
| Hypertension |
33.6% |
| Product Used For Unknown Indication |
11.6% |
| Hepatitis C |
9.5% |
| Cardiac Failure |
6.3% |
| Pain |
4.4% |
| Depression |
4.0% |
| Coronary Artery Disease |
3.9% |
| Constipation |
3.2% |
| Asthma |
3.0% |
| Dyspepsia |
3.0% |
| Type 2 Diabetes Mellitus |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
| Diabetes Mellitus |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Myocardial Infarction |
1.9% |
| Drug Use For Unknown Indication |
1.6% |
| Hyperlipidaemia |
1.5% |
| Sleep Disorder |
1.3% |
| Atrial Fibrillation |
1.2% |
| Ischaemic Heart Disease Prophylaxis |
1.2% |
|
| Drug Interaction |
19.3% |
| Renal Failure Acute |
17.1% |
| Neutropenia |
10.5% |
| Syncope |
8.8% |
| Vomiting |
7.7% |
| Hyperkalaemia |
4.4% |
| Rhabdomyolysis |
3.9% |
| Hypotension |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Dehydration |
2.8% |
| Hypertensive Crisis |
2.8% |
| Atrioventricular Block Complete |
2.2% |
| Hypoglycaemia |
2.2% |
| Potentiating Drug Interaction |
2.2% |
| Renal Failure |
2.2% |
| Malaise |
1.7% |
| Neuralgia |
1.7% |
| Sleep Disorder |
1.7% |
| Circulatory Collapse |
1.1% |
| Delirium |
1.1% |
|
